Palmetto General Hospital First in Florida to Implant New FDA-Approved Sutureless Aortic ValveFeb 12, 2020
Miami, Fla. (October 19, 2016) – Palmetto General Hospital is the first hospital in Florida and third in the United States to commercially implant a sutureless aortic valve in a patient with heart valve disease through a newly FDA-approved, minimally invasive delivery system.
The advanced EDWARDS INTUITY Elite valve system is a deployment device that incorporates some elements of transcatheter aortic valve replacement (TAVR), a minimally invasive valve replacement procedure. The system is designed to streamline complex aortic valve replacements and result in less trauma to the body and quicker recovery times. The surgeon replaces a patient’s valve through an incision in the ribs, and it is delivered via a catheter into the heart.
“We are constantly researching the latest technologies and procedures to meet the ever-changing needs of our patients,” said Ana Mederos, CEO of Palmetto General Hospital. “We are pleased to enhance our medical services with the addition of this valve system and offer our patients a new option.”
Traditionally, open heart surgery is the preferred method for valve replacement but more cardiologists and cardiac surgeons are turning to minimally invasive approaches.
The Heart Institute at Palmetto General Hospital offers a comprehensive multi-specialty program devoted to heart and vascular health that addresses each patient’s particular needs. For more information on the cardiovascular services offered at Palmetto General Hospital, please call (888) 620-1932.